Ebtehal El-Demerdash Selected Research

trichrome stain

1/2020	Mechanistic aspects of antifibrotic effects of honokiol in Con A-induced liver fibrosis in rats: Emphasis on TGF-β/SMAD/MAPK signaling pathways.
1/2018	The potential antifibrotic impact of apocynin and alpha-lipoic acid in concanavalin A-induced liver fibrosis in rats: Role of NADPH oxidases 1 and 4.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ebtehal El-Demerdash Research Topics

Disease

18	Neoplasms (Cancer) 11/2023 - 10/2008
15	Liver Cirrhosis (Hepatic Cirrhosis) 09/2022 - 02/2008
13	Fibrosis (Cirrhosis) 04/2021 - 02/2008
11	Inflammation (Inflammations) 10/2021 - 06/2012
9	Cardiotoxicity 10/2021 - 11/2003
8	Insulin Resistance 09/2022 - 06/2010
5	Cognitive Dysfunction 03/2024 - 03/2021
5	Breast Neoplasms (Breast Cancer) 11/2023 - 09/2005
4	Neuroinflammatory Diseases 07/2023 - 03/2021
4	Primary Ovarian Insufficiency 01/2021 - 01/2012
3	Chemotherapy-Related Cognitive Impairment 03/2024 - 03/2021
3	Cardiomyopathies (Cardiomyopathy) 08/2021 - 11/2003
3	Hepatocellular Carcinoma (Hepatoma) 01/2016 - 01/2009
2	Hypoxia (Hypoxemia) 11/2023 - 01/2022
2	Stomach Ulcer (Gastric Ulcer) 01/2023 - 01/2018
2	Ulcer 01/2023 - 01/2018
2	Myocardial Infarction 01/2022 - 10/2021
2	Weight Gain 12/2021 - 11/2021
2	Dyslipidemias (Dyslipidemia) 11/2021 - 01/2020
2	Liver Diseases (Liver Disease) 10/2021 - 01/2016
2	Fatty Liver 10/2021 - 01/2020
2	Hypertriglyceridemia 10/2021 - 06/2010
2	Non-alcoholic Fatty Liver Disease 04/2021 - 01/2020
2	Necrosis 04/2021 - 01/2018
2	Type 2 Diabetes Mellitus (MODY) 08/2020 - 01/2011
2	Edema (Dropsy) 01/2020 - 10/2012
2	Alcoholic Fatty Liver 01/2020 - 01/2020
2	Iron Overload 11/2019 - 11/2015
2	Infertility (Sterility) 10/2019 - 01/2012
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 12/2012 - 08/2011
2	Hemorrhage 06/2012 - 04/2005
1	Nausea 03/2024
1	Vomiting 03/2024

Drug/Important Bio-Agent (IBA)

11	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 11/2003
11	AntioxidantsIBA 11/2019 - 04/2005
10	Hydroxyproline (4 Hydroxyproline)IBA 01/2020 - 02/2008
9	CollagenIBA 04/2021 - 06/2012
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 10/2012
5	LipidsIBA 12/2021 - 04/2005
4	Tamoxifen FDA LinkGeneric 11/2023 - 09/2005
4	NF-kappa B (NF-kB)IBA 01/2022 - 06/2012
4	Interleukin-6 (Interleukin 6)IBA 01/2020 - 01/2011
4	Concanavalin AIBA 01/2020 - 11/2015
3	Cisplatin (Platino)FDA LinkGeneric 03/2024 - 12/2021
3	Taurine FDA Link 11/2023 - 06/2010
3	Therapeutic UsesIBA 01/2023 - 07/2020
3	Isoproterenol (Isoprenaline)FDA LinkGeneric 01/2022 - 04/2005
3	FlavonoidsIBA 10/2021 - 01/2018
3	CateninsIBA 10/2021 - 01/2020
3	Carvedilol (Coreg)FDA LinkGeneric 10/2021 - 06/2012
3	CytokinesIBA 04/2021 - 03/2016
3	Proteins (Proteins, Gene)FDA Link 03/2021 - 03/2012
3	IronIBA 11/2019 - 11/2015
3	chrysinIBA 01/2018 - 04/2014
3	Creatine Kinase (Creatine Phosphokinase)IBA 02/2016 - 11/2003
3	2-MethoxyestradiolIBA 01/2009 - 10/2008
2	Neuroprotective AgentsIBA 03/2024 - 01/2022
2	Long Noncoding RNAIBA 11/2023 - 01/2022
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 11/2023 - 03/2016
2	MicroRNAs (MicroRNA)IBA 11/2023 - 01/2022
2	Sirtuin 3IBA 11/2023 - 01/2022
2	Caspase 3 (Caspase-3)IBA 03/2023 - 01/2009
2	Proliferating Cell Nuclear Antigen (PCNA)IBA 03/2023 - 06/2014
2	Indomethacin (Indometacin)FDA LinkGeneric 01/2023 - 01/2018
2	AcidsIBA 01/2023 - 01/2018
2	Blood Glucose (Blood Sugar)IBA 09/2022 - 01/2020
2	thymoquinoneIBA 01/2022 - 12/2012
2	Antipsychotic Agents (Antipsychotics)IBA 12/2021 - 11/2021
2	Glucose (Dextrose)FDA LinkGeneric 11/2021 - 06/2010
2	Transaminases (Aminotransferases)IBA 10/2021 - 01/2020
2	Insulin (Novolin)FDA Link 08/2020 - 01/2018
2	Propolis (Bee Bread)IBA 07/2020 - 03/2018
2	trichrome stainIBA 01/2020 - 01/2018
2	Transforming Growth Factor beta (TGF-beta)IBA 01/2020 - 01/2016
2	Chelating AgentsIBA 11/2019 - 11/2015
2	EnzymesIBA 01/2018 - 06/2012
2	flavoneIBA 01/2017 - 04/2014
2	Deferoxamine (Desferal)FDA LinkGeneric 01/2016 - 11/2015
2	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 06/2015 - 03/2013
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2013 - 06/2010
2	Glutathione (Reduced Glutathione)IBA 01/2013 - 02/2008
2	Bleomycin (Blenoxane)FDA LinkGeneric 12/2012 - 08/2011
2	Lipid PeroxidesIBA 06/2012 - 02/2008
2	Epirubicin (Ellence)FDA LinkGeneric 03/2012 - 09/2005
2	Estrogens (Estrogen)FDA Link 01/2012 - 09/2005
2	Probucol (Lorelco)FDA Link 04/2005 - 11/2003
1	NLR ProteinsIBA 03/2024
1	Ondansetron (Zofran)FDA LinkGeneric 03/2024
1	Serotonin 5-HT3 Receptor AntagonistsIBA 03/2024
1	InflammasomesIBA 03/2024
1	Nerve Growth Factors (Neurotrophins)IBA 07/2023
1	Protective AgentsIBA 07/2023
1	Neurotransmitter Agents (Neurotransmitter)IBA 07/2023
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 07/2023
1	Antineoplastic Agents (Antineoplastics)IBA 03/2023
1	Tolonium Chloride FDA Link 03/2023
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 03/2023

Therapy/Procedure

7	Therapeutics 01/2022 - 10/2008
6	Radiotherapy 01/2021 - 01/2012
3	Drug Therapy (Chemotherapy) 03/2024 - 03/2021